Associations between CMV-IgM antibody levels may contribute to the role of CMV in the pathogenesis of MDA5+ DM by regulating lymphocyte subsets, such as decreasing CD4+ T cells and CD19+ B cells. This evidence concerns the gene CD40LG and dermatomyositis.